Roth Capital Starts Apricus Biosciences (APRI) at Buy
Tweet
Share
E-mailGet Alerts APRI Hot Sheet
Price: $0.22 --0%
Rating Summary:
4 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 17 | New: 28
Rating Summary:
4 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 17 | New: 28
Join SI Premium – FREE
Roth Capital initiates coverage on Apricus Biosciences (NASDAQ: APRI) with a Buy.
For an analyst ratings summary and ratings history on Apricus Biosciences click here. For more ratings news on Apricus Biosciences click here.
Shares of Apricus Biosciences closed at $2.49 yesterday.
For an analyst ratings summary and ratings history on Apricus Biosciences click here. For more ratings news on Apricus Biosciences click here.
Shares of Apricus Biosciences closed at $2.49 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Starts Granite Ridge Resources (GRNT) at Outperform, 'Deep Discount & Moving to FCF+'
- Wolfe Research Starts Baker Hughes (BKR) at Outperform, 'FcF trajectory being mispriced at an OFS multiple'
- Wells Fargo Assumes T-Mobile (TMUS) at Equal Weight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
